Paulus Kirchhof

Paulus Kirchhof

Director of the Institute of Cardiovascular Sciences AND Chair in Cardiovascular Medicine

University of Birmingham, UK

  • LinkedIn
  • Radcliffe

Biography

Prof Kirchhof is the Director of the Institute of Cardiovascular Sciences at the University of Birmingham. Prof Kirchhof research includes novel molecular mechanisms of heart disease that can be leveraged to develop personalised treatment approaches to common cardiovascular diseases.

Read more

Media

Jose L Merino, Jason G Andrade, Dhiraj Gupta, et al

EHRA 22: EAST-AFNET 4 in Clinical Practice

Paulus Kirchhof,

Carina Blomström-Lundqvist, Jason G Andrade, Yassir Javaid, et al

ESC 2020: EAST – AFNET 4 Study

Paulus Kirchhof,

ESC 2020: The BioSync CLS Study

Paulus Kirchhof,

EHRA 2018: AXAFA Trial

Paulus Kirchhof, Afzal Sohaib,

A John Camm, Paulus Kirchhof, Raffaele De Caterina, et al

NOAC

Paulus Kirchhof, A John Camm, Marco Alings, et al

NOAC

A John Camm, Raffaele De Caterina, Paulus Kirchhof, et al

NOAC

Freek WA Verheugt, A John Camm, Paulus Kirchhof, et al

NOAC

A John Camm, Paulus Kirchhof, Freek WA Verheugt, et al

A John Camm, Marco Alings, Raffaele De Caterina, et al

What's new in the ESC Guidelines on cardiac pacing - ESC TV

Michele Brignole, Paulus Kirchhof,

Articles by Paulus Kirchhof, Director of the Institute of Cardiovascular Sciences AND Chair in Cardiovascular Medicine

Real-world versus Clinical Trial Data with NOACs

Paulus Kirchhof,

Published:

Citation: Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):3-5

DOI:

https://doi.org/10.15420/aer.2015.4.1.S1